Literature DB >> 16407834

Cbl escapes Cdc42-mediated inhibition by downregulation of the adaptor molecule betaPix.

M H H Schmidt1, K Husnjak, I Szymkiewicz, K Haglund, I Dikic.   

Abstract

The Pix/Cool proteins are involved in the regulation of cell morphology by binding to small Rho GTPases and kinases of the Pak family. Recently, it has been shown that betaPix/Cool-1 associates with the ubiquitin ligase Cbl, which appears to be a critical step in Cdc42-mediated inhibition of epidermal-growth-factor-receptor (EGFR) ubiquitylation and downregulation. Here we show that the SH3 domain of betaPix specifically interacts with a proline-arginine motif (PxxxPR) present within the ubiquitin ligase Cbl and Pak1 kinase. Owing to targeting of the same sequence, Cbl and Pak1 compete for binding to betaPix. In this complex, Cbl mediates ubiquitylation and subsequent degradation of betaPix. Our findings reveal a double feedback loop in which the Cdc42/betaPix complex blocks Cbl's ability to downregulate EGFR, while Cbl in turn promotes degradation of betaPix in order to escape this inhibition. Such a relationship provides a mechanism to fine-tune the kinetics of RTK endocytosis and degradation depending on the pool of active Cdc42 and the duration of EGFR signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407834     DOI: 10.1038/sj.onc.1209329

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

Review 1.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

2.  Shank2 redistributes with NaPilla during regulated endocytosis.

Authors:  Evgenia Dobrinskikh; Hector Giral; Yupanqui A Caldas; Moshe Levi; R Brian Doctor
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-01       Impact factor: 4.249

Review 3.  Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.

Authors:  Byung Min Chung; Eric Tom; Neha Zutshi; Timothy Alan Bielecki; Vimla Band; Hamid Band
Journal:  World J Clin Oncol       Date:  2014-12-10

4.  Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity.

Authors:  Susanne Rauch; Kati Pulkkinen; Kalle Saksela; Oliver T Fackler
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 5.  Roles of P21-activated kinases and associated proteins in epithelial wound healing.

Authors:  Mirjam Zegers
Journal:  Int Rev Cell Mol Biol       Date:  2008       Impact factor: 6.813

6.  Role of βPix in the Kidney.

Authors:  Alexander Staruschenko; Andrey Sorokin
Journal:  Front Physiol       Date:  2012-05-28       Impact factor: 4.566

7.  αPIX Is a Trafficking Regulator that Balances Recycling and Degradation of the Epidermal Growth Factor Receptor.

Authors:  Fanny Kortüm; Frederike Leonie Harms; Natascha Hennighausen; Georg Rosenberger
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

8.  Threshold-controlled ubiquitination of the EGFR directs receptor fate.

Authors:  Sara Sigismund; Veronica Algisi; Gilda Nappo; Alexia Conte; Roberta Pascolutti; Alessandro Cuomo; Tiziana Bonaldi; Elisabetta Argenzio; Lisette G G C Verhoef; Elena Maspero; Fabrizio Bianchi; Fabrizio Capuani; Andrea Ciliberto; Simona Polo; Pier Paolo Di Fiore
Journal:  EMBO J       Date:  2013-06-25       Impact factor: 11.598

9.  Cdc42 and Par proteins stabilize dynamic adherens junctions in the Drosophila neuroectoderm through regulation of apical endocytosis.

Authors:  Kathryn P Harris; Ulrich Tepass
Journal:  J Cell Biol       Date:  2008-12-08       Impact factor: 10.539

10.  Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells.

Authors:  Hsing-Yu Chen; Yin M Yang; Brett M Stevens; Mark Noble
Journal:  EMBO Mol Med       Date:  2013-04-22       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.